Pharmaniaga Bhd said the contract would strengthen the group’s recurring revenue base within the public healthcare segment while enhancing earnings visibility. PETALING JAYA: Pharmaniaga Bhd has secured a three-year RM281.7 million contract from the health ministry through its wholly owned subsidiary, Pharmaniaga LifeScience Sdn Bhd, to supply human insulin to healthcare facilities nationwide. The pharmaceutical company said the contract represe…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.